We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

MODULA Modul 5 BEAT-HF

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00273091
First Posted: January 9, 2006
Last Update Posted: February 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Guidant Corporation
Information provided by:
Boston Scientific Corporation
  Purpose
Detektion and Registration of Atrial Tachyarrhythmias at Patients with Heart Failure; What proportion of patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia?

Condition Intervention
Heart Failure Device: ICD with CRT therapy

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: MODULA-Study: Modul 5 / BEAT HF: Detektion and Registration of Atrial Tachyarrhythmias at Patients With Heart Failure

Resource links provided by NLM:


Further study details as provided by Boston Scientific Corporation:

Primary Outcome Measures:
  • Occurrence of atrial tachycardia in CRT patients [ Time Frame: 12 months ]

Estimated Enrollment: 100
Study Start Date: August 2003
Study Completion Date: May 2007
Intervention Details:
    Device: ICD with CRT therapy
    permanently CRT pacing
Detailed Description:
How many patients with CRT-therapy are affected at least temporarily by Atrial Arrhythmia in terms of rate, characteristics and severity of atrial rhythm disturbances at patients with CRT-therapy within 12 months after implantation of a CRT-device.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Elegible patients comprise the investiagators standard CRT-D population.
Criteria

Inclusion Criteria:

  • patient under CRT-D or CRT-P therapy

Exclusion Criteria:

  • patients with permanent Atrial Fibrillation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00273091


Locations
Germany
Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9
Bad Berka, Germany
Sponsors and Collaborators
Boston Scientific Corporation
Guidant Corporation
Investigators
Principal Investigator: Burkhard J. Hügl, phd Herzzentrum / Klinik für Kardiologie / Robert-Koch-Allee 9 / 99437 Bad Berka / Germany
  More Information

Responsible Party: jens goetzke, guidant germany a boston scientific company
ClinicalTrials.gov Identifier: NCT00273091     History of Changes
Other Study ID Numbers: Version vom 10.07.2003
First Submitted: January 5, 2006
First Posted: January 9, 2006
Last Update Posted: February 23, 2017
Last Verified: February 2017

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases